SuperworthGinkgo Bioworks shares outstanding DNA
Diluted shares outstanding, averaged over each quarter, from 2020.
- Latest quarter, to Dec 31, 2025
- 57.1M
- On a year earlier
- +6.0%
- more shares
Ginkgo Bioworks had 57.1M diluted shares outstanding on average in Q4 FY25, the quarter to Dec 31, 2025.
That is 6.0% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 57.1M | +6% |
| FY2024 | 53.8M | +9% |
| FY2023 | 49.4M | +7% |
| FY2022 | 46.4M | +21% |
| FY2021 | 38.3M | +19% |
| FY2020 | 32.2M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q4 FY25 | 57.1M | +6% | |
| Q3 FY25 | 55.6M | +6% | |
| Q2 FY25 | 54.9M | +7% | |
| Q1 FY25 | 54.2M | +8% | |
| Q4 FY24 | 53.8M | +9% | |
| Q3 FY24 | 52.2M | +7% | |
| Q2 FY24 | 51.4M | +6% | |
| Q1 FY24 | 50.1M | +5% | |
| Q4 FY23 | 49.4M | +7% | |
| Q3 FY23 | 48.8M | +20% | |
| Q2 FY23 | 48.3M | +19% | |
| Q1 FY23 | 47.9M | +19% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Ginkgo Bioworks
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.